Juan Villaverde called the top and bottom of every crypto bull market since 2012. He believes Bitcoin will go to $150,000 — or more. But there’s one coin he thinks could go even higher.

Douglas Doerfler Biography and Net Worth

Founder of MaxCyte

Mr. Doerfler has 35+ years of vast experience in biotechnology product and company development, commercialisation and international financing. He was a founder of MaxCyte in July 1998. Previously, he was President, CEO and a Director of Immunicon Corporation. He also held various executive positions with Life Technologies, Inc. (now Thermo Fisher).

Mr. Doerfler is an active Life Sciences industry advocate, serving as Chair Emeritus of the Maryland Tech Council and on the executive committee of the Biotechnology Innovation Organization. He received his BS in finance from the University of Baltimore School of Business, and holds an Industrial Relations certificate.

How old is Douglas Arthur Doerfler?: Mr. Doerfler is currently 68 years old. There are 6 older executives and no younger executives at MaxCyte. The oldest executive at MaxCyte is Dr. J. Stark Thompson Ph.D., Consultant, who is 82 years old. Learn More on Douglas Arthur Doerfler's age.
How do I contact Douglas Arthur Doerfler?: The corporate mailing address for Mr. Doerfler and other MaxCyte executives is 22 FIRSTFIELD ROAD SUITE 110, GAITHERSBURG MD, 20878. MaxCyte can also be reached via phone at 301-944-1700 and via email at [email protected]. Learn More on Douglas Arthur Doerfler's contact information.
Has Douglas Arthur Doerfler been buying or selling shares of MaxCyte?: Douglas Arthur Doerfler has not been actively trading shares of MaxCyte during the last ninety days. Learn More on Douglas Arthur Doerfler's trading history.
Are insiders buying or selling shares of MaxCyte?: In the last year, MaxCyte insiders bought shares 2 times. They purchased a total of 100,000 shares worth more than $489,113.29. In the last year, insiders at the sold shares 16 times. They sold a total of 181,264 shares worth more than $770,069.90. The most recent insider tranaction occured on October, 28th when Director John Joseph Johnston sold 3,000 shares worth more than $11,160.00. Insiders at MaxCyte own 3.0% of the company. Learn More about insider trades at MaxCyte.
Information on this page was last updated on 10/28/2024.

Douglas Arthur Doerfler Insider Trading History at MaxCyte

Douglas Arthur Doerfler Buying and Selling Activity at MaxCyte

MaxCyte Company Overview

MaxCyte, Inc., a life sciences company, discovers, develops, and commercializes next-generation cell therapies in the United States and internationally. Its products include ExPERT ATx, a static electroporation instrument for small to medium scale transfection; ExPERT STx, a flow electroporation for protein production and drug development, as well as expression of therapeutic targets for cell-based assays; ExPERT GTx, a flow electroporation for large scale transfection in therapeutic applications; and ExPERT VLx for very large volume cell-engineering. The company also provides disposable processing assemblies (PAs) to process and electroporate cells; and accessories supporting PAs, such as electroporation buffer solution and software protocols. It licenses and sells its instruments and technology; and sells its consumables to developers of cell therapies, as well as to pharmaceutical and biotechnology companies for use in drug discovery and development, and bio-manufacturing. MaxCyte, Inc. was incorporated in 1998 and is headquartered in Rockville, Maryland.

Today's Range

Now: $3.47

$3.41

$3.48

50 Day Range

MA: $3.75

$3.23

$4.35

2 Week Range

Now: $3.47

$3.16

$5.55

Volume

103,614 shs

Average Volume

519,044 shs

Market Capitalization

$366.02 million

P/E Ratio

N/A

Dividend Yield

N/A

Beta

1.4

Trump won. Buy this coin now.

From Weiss Ratings | Ad